Certepetide是一种双功能环肽，其RGD基序可与α-V整合素结合并激活神经纤毛蛋白-1，从而将实体瘤微环境转化为临时药物递送通道。该肽能特异性靶向并富集于肿瘤组织，适用于胰腺癌及其他实体瘤的研究。

/

-85~-65℃避光保存，有效期2年。

[1] Järveläinen HA，Schmithals C，von Harten M，Kakoschky B，Vogl TJ，Harris S，Henson C，Bullen-Clerkson G，Piiper A,Assessment of the Pharmacokinetics，Disposition，and Duration of Action of the Tumour-Targeting Peptide CEND-1,Int J Mol Sci,2023 Mar 16;24(6):5700,doi: 10.3390/ijms24065700,PMID: 36982773;PMCID: PMC10053770.[2]Schmithals C，Köberle V，Korkusuz H，Pleli T，Kakoschky B，Augusto EA，Ibrahim AA，Arencibia JM，Vafaizadeh V，Groner B，Korf HW，Kronenberger B，Zeuzem S，Vogl TJ，Waidmann O，Piiper A,Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma,Cancer Res,2015 Aug 1;75(15):3147-54,doi: 10.1158/0008-5472.CAN-15-0395,PMID: 26239478.